Yes, sumatriptan is an abortive medication for acute migraine attacks.
Sumatriptan is a migraine-specific abortive therapy, not a preventive medication. It belongs to the triptan class (5-HT1B/1D receptor agonists) and is specifically indicated for the acute treatment of migraine with or without aura in adults 1. The FDA label explicitly states that sumatriptan is "not indicated for the prevention of migraine attacks" 1.
How Sumatriptan Works as Abortive Therapy
Sumatriptan functions as a selective serotonin receptor agonist that works to abort migraine attacks once they have begun 2. The guidelines consistently classify triptans, including sumatriptan, as migraine-specific abortive agents reserved for moderate to severe migraines or mild to moderate migraines unresponsive to NSAIDs 2, 3.
Clinical Positioning in Treatment Algorithm
First-line approach: Start with NSAIDs (aspirin, ibuprofen, naproxen) for most migraine sufferers 3.
Second-line approach: When NSAIDs fail or for moderate to severe attacks, use migraine-specific agents like triptans 3. Sumatriptan should be administered as early as possible during an attack to improve efficacy 2.
Optimal strategy: The most recent 2025 guideline recommends adding a triptan to an NSAID (or acetaminophen when NSAIDs are contraindicated) for patients who don't achieve sufficient pain relief with NSAIDs alone 4. This combination approach provides superior efficacy compared to either medication alone 5, 6.
Route-Specific Efficacy
Sumatriptan's abortive effectiveness varies by administration route 7:
- Subcutaneous (6 mg): Most effective—59% pain-free at 2 hours versus 15% with placebo (NNT 2.3), with peak concentration in approximately 15 minutes 2, 8
- Oral (50-100 mg): 28% pain-free at 2 hours with 50 mg versus 11% with placebo (NNT 6.1) 2, 9
- Intranasal (20 mg): NNT 4.7 for pain-free at 2 hours 10
- Rectal (25 mg): Limited data but shows efficacy 7
Critical Clinical Considerations
Timing matters: Treating early when pain is still mild produces significantly better outcomes than waiting until pain becomes moderate or severe 2, 9. This is a key principle for maximizing abortive efficacy.
Contraindications: Do not use in patients with ischemic vascular conditions, vasospastic coronary disease, uncontrolled hypertension, or significant cardiovascular disease 2, 1. These are absolute contraindications due to the vasoconstrictive properties of triptans.
Medication overuse headache: Limit triptan use to no more than 10 days per month to prevent medication-overuse headache 3, 4, 11. This is a critical pitfall—overuse of abortive medications can paradoxically worsen headache frequency.
Trial multiple triptans: If one triptan is ineffective, try a different one before abandoning the class entirely 2. Individual response varies significantly among triptans.
Route selection: Choose non-oral routes (subcutaneous or intranasal) for patients with significant nausea or vomiting as part of their migraine presentation 3, 4.
When to Consider Preventive Therapy Instead
Evaluate for preventive therapy when patients use abortive medication more than twice per week, have two or more attacks per month producing disability lasting 3+ days, or when acute treatments fail or are contraindicated 3. At that point, the focus shifts from abortive to preventive strategies using medications like propranolol, amitriptyline, or valproate.